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Abstract 
Opioid drug misuse and dependence are a social and public health problem in the United 
States. Prescription opioid abuse and misuse have been associated with substantial 
morbidity and mortality rates as well as social and economic costs. The purpose of this 
project was to provide a systematic review of literature on the effectiveness of 
medication-assisted therapy interventions in addressing the problem of prescription 
opioid misuse in health care settings. The systematic review was completed through a 
literature search conducted across five electronic databases. The review was guided by 
the health belief model and eligible studies were rated using Johns Hopkins hierarchy of 
evidence. Fifteen peer-reviewed journal articles published from 2011 met the inclusion 
criteria and were reviewed in full.  Of these, 14 were randomized controlled trials and 1 
was a quasi-experimental study. The most commonly explored interventions were 
psychosocial interventions in conjunction with medications for opioid addiction. Review 
findings provided moderate evidence to support the effectiveness of psychosocial 
interventions in conjunction with medications in the treatment of opioid dependence, 
although the strength of the efficacy varied depending on the intervention provided. This 
project may advance nursing field by promoting provision of care to opioid dependent 
patients based on the best available evidence. Evidence-based care to patients with 
prescription opioid dependence will positively impact social change by improving the 
quality of life of patients, relieving caregivers of the burden of monitoring the addicted 
patients and saving millions of dollars spent in the criminal justice and health care 
systems.   
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Section I: Overview of the Evidence-Based Project 
Introduction 
Opioid drug misuse and dependence is a major social and public health problem 
in the United States (U.S) that has reached epidemic levels in the past few decades (Rudd 
et al., 2016). Indeed, about 2 million U.S. adults abused or were addicted to prescription 
opioids in the year 2014 (Hedden, 2015). Researchers have found that at least one in four 
people who have received prescription opioids for pain not related to cancer become 
addicted at some point (Boscarino et al., 2010). According to Crane (2013), at least 1,000 
people are received daily in emergency departments as a result of abusing prescription 
opioids. Addiction to opioid has been associated with substantial health risks including 
the transmission of viral infections such as hepatitis B and C as well as Human 
Immunodeficiency Virus (HIV) (Suryaprasad et al., 2014). Prospective studies have 
shown that the risk of adverse health outcomes continues for many years after a diagnosis 
suggesting that opioid dependence may be considered a chronic health condition (Edlund 
et al., 2014; Hser, Evans, Grella, Ling, & Anglin, 2015).  
 Besides the adverse health effects associated with this form of substance misuse, 
the use of opioids (including heroin and prescription opioids) led to the death of around 
33,000 people in 2015, the highest mortality rate that has ever been reported (Center for 
Disease Control and Prevention [CDC], 2017), suggesting that the mortality rate has been 
increasing. Likewise, the National Institute on Drug Abuse (2017) reported that overdose 
deaths related to prescription opioids increased three times between 2001 and 2015. 
Almost 50% of all deaths related to opioid misuse involve a prescription opioid (Kolodny 
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et al., 2015), highlighting the role of health care providers in promoting the health of 
people misusing opioids.  
Beyond the high mortality and morbidity rates, dependence on opioid inflicts 
huge social and economic costs as a result of lost productivity, breakdown in 
relationships, health care costs, and expenses related to law enforcement. It is estimated 
that prescription opioid misuse and dependence carries a high economic burden for the 
U.S, with the aggregate economic burden projected at $78.5 billion (Florence, Zhou, Luo, 
& Xu, 2016). About 25% of this cost is borne by the public health care sector, substance 
use therapy, and the costs incurred in the criminal justice system (Florence et al., 2016). 
The findings shed light on the economic effect of opioid abuse and dependence; hence 
highlighting the need to develop strategies aimed at reducing the social, economic, and 
public health burden.  
This project has implications for positive social change. In this project I have 
provided a systematic and a critical review of the existing evidence on the effectiveness 
of medication-assisted therapy interventions in reducing the problem of opioid misuse 
and dependence in primary care setting. As a result, the study will ensure that nurse 
practitioners stay at par with the best evidence on treatment of opioid dependence and 
abuse. This will ascertain that they are able to provide evidence-based care to opioid 
dependence patients leading to optimal patient outcomes, reduced health care costs, and 
reduced mortality rate attributable to substance misuse. 
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Problem Statement 
Statistics on the prevalence of substance abuse indicate that substance use 
disorder is a severe public health issue that requires evidence-based interventions. Public 
health officials among other policymakers seem to have reached a consensus that the 
opioid epidemic cannot be adequately resolved through the current punitive drug policies 
(Substance Abuse and Mental Health Services Administration (SAMHSA) 2013; 
Volkow, 2014). As a result, training programs aimed at impacting nurse practitioners 
with the knowledge and appropriate skills to provide effective medication-assisted 
therapies for patients on opioids are being offered in the U.S.  
Nurse practitioners are ideally suited to carry out substance abuse interventions 
because of their knowledge in the setting of health promotion (Nyamathi et al., 2011). 
According to Lock et al. (2006), nurse-led interventions are effective in addressing 
behavioral problems related to chronic alcohol intake among patients seeking care in the 
primary care setting.  However, information is lacking about the effectiveness of a nurse-
led intervention designed to reduce opioid abuse among adults receiving medication-
assisted therapy in primary care settings. Therefore, the purpose of the capstone project 
was to provide a systematic review of the literature on the effectiveness of medication-
assisted therapy interventions in reducing the problem of opioid misuse and dependence 
by adults seen in primary care settings.  
Purpose Statement 
The purpose of this capstone DNP project was to synthesize the best available 
evidence on the effectiveness of medication-assisted therapy interventions in reducing the 
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problem of opioid misuse and dependence by adults seen in primary care settings. A gap 
exists in practice when nurse practitioners or other health care providers administer 
interventions that are not supported by the best available evidence (Solomon, 2016), and 
it was the purpose of this project to address such a gap. Thus, a systematic review is in 
accord with the American Nurse Practitioner Association (ANA) position that as 
providers offering care on the front lines of the opioid epidemic, registered nurse 
practitioners are qualified and have a responsibility to play a leading role in monitoring 
and managing patients struggling with this form of addiction (ANA, 2015). The identified 
gap was addressed by conducting a systematic review of the existing empirical research 
on the effectiveness of medication assisted therapy in dealing with the problem of 
prescription opioid misuse and abuse by patients. 
The population, intervention, comparison, and outcomes (PICO) question for this 
project was: Does medication-assisted therapy interventions reduce the problem of opioid 
dependence and misuse by adults seen in primary care settings? The population of 
interest includes adult patients who are opiate addicts receiving care in primary settings, 
the interventions and comparison include both pharmacotherapeutic and psychological 
management of opioid addiction while the outcome measures of interest include abstinent 
at follow up, withdrawal of signs and symptoms, adverse effects of treatment, and 
completion of treatment.  
The project has the potential to address the identified practice gap. It provided 
scholarly information on best practices for the provision of medication-assisted therapies 
by nurse practitioners to manage the problem of opioid misuse among patients seeking 
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care at the practicum site. The evidence on best practices will empower practice nurse 
practitioners in the mental health setting to make best decisions regarding patient care 
based on EBP rather than rituals, traditions, and opinions by colleagues. The evidence 
can also be used to develop educational programs aimed at raising nurse practitioner 
knowledge and skills to offer effective medication-assisted therapies to opioid dependent 
patients.   
Nature of the Doctoral Project 
There is a broad range of treatment options including psychosocial and 
pharmacotherapeutic interventions that have been approved to treat opioid dependence. 
There are currently three types of medications that have been approved for treatment of 
opioid dependence, including naltrexone, buprenorphine, and methadone (Volkow et al., 
2014). Each of these drugs is to be used within a framework of social, medical, and 
cognitive support which is part of the inclusive opioid dependence treatment approach 
(Volkow et al., 2014). Nevertheless, there is a scarcity of reviews assessing the 
effectiveness of medication-assisted therapy interventions by nurse practitioners in 
reducing the problem of opioid misuse by adults seen in primary care (Brady, McCauley, 
& Back, 2015). As a result, the purpose of the capstone project was to provide a 
systematic review of literature on the effectiveness of medication-assisted therapy 
interventions by nurse practitioners in reducing the problem of prescription opioid misuse 
by adults seen in primary care settings. 
To accomplish the purpose of the review, a literature search was carried out to 
identify appropriate sources of evidence. Articles on the effectiveness of medication-
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assisted therapies were collected. Procedures followed in this review included defining 
the research question, developing a literature search strategy, searching and identifying 
relevant sources, extracting and analyzing data, and presenting and disseminating the 
findings (Higgins & Green, 2011). The search for the literature focused on primary 
studies as the main source of evidence. The search was conducted through five electronic 
databases including EMBASE, CINAHL, PubMed, Cochrane Library, and PsyINFO. 
Search terms related to psychosocial treatment, opioid dependence, addiction, medication 
assisted therapy, and effectiveness were developed. The search was restricted to materials 
available in full, published within the past decade and available in English language. The 
title and abstracts of the articles were reviewed before downloading them and 
determining their relevance. The findings will later be shared with the nurse practitioners 
at my practicum setting and regional conferences held by mental health nurse 
practitioners. An elaborate description of the sources of evidence is presented in Section 
3.  
Significance 
Evidence-based practice (EBP) is crucial in the provision of quality care to 
patients suffering from opioid dependence problems (Volkow et al., 2014). This capstone 
project has the potential to strengthen EBP in the management of patients presenting with 
opioid dependence in health care settings. The project was carried out through a 
systematic review of the existing evidence on the effectiveness of medication assisted 
interventions in reducing opioid dependence symptoms as well as promoting abstinence 
in both the short and long-term. As a result, the capstone project provided the best 
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available evidence on the management of opioid dependent patients thus empowering 
nurse practitioners and other health care providers to make decisions regarding patient 
care on the basis of the best available evidence rather than on traditions, rituals, and 
opinions from colleagues. The literature reviewed has demonstrated the magnitude and 
the burden posed by prescription opioid dependence on the health care system and 
society in general (Edlund et al., 2014; Kolodny et al., 2015; Rudd et al., 2016); thus 
demonstrating the importance of adopting the EBP to tackle the problem.  
Implications for Social Change in Practice 
As an advanced practice registered nurse (ANRP) who acts as an agent of change 
for adoption of EBP, quality improvements efforts to promote the provision of care that is 
consistent with the patient needs and supported by the best available evidence is essential 
(Sperhac & Clinton, 2008). Nurse practitioners with a doctoral degree have a key 
responsibility of shaping policies that could have an impact on nursing practice as well as 
patient outcomes (Zaccagnini & White, 2015). The DNP capstone project was carried out 
through a systematic review of literature approach, and the best available evidence was 
synthesized to inform practice on the effectiveness of treatment strategies used to manage 
opioid dependence. A review of literature highlighted a practice problem where health 
care providers including nurse practitioners have poor prescription practices for the 
management of opioid dependence (Solomon, 2016).  
Health promotion is an essential role of a nurse with a doctoral degree (Sperhac & 
Clinton, 2008). Evidence obtained from this capstone project could be used to advance 
nursing practice by promoting safe and effective treatment methods for opioid 
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dependence. The findings of the review can also promote practice change by providing 
evidence-based models for management of patients suffering from opioid dependence. 
Nurse practitioners ought to advocate for improved access of opioid dependence patients 
to treatment programs providing evidence-based care. This will ensure that patients 
benefit from the provision of patient-centered care that meets their short and long-term 
needs.  
The DNP project has the capacity to promote further positive social change in the 
near future. Provision of care that is consistent with the patient needs and the best 
available scientific evidence will positively impact social change by improving the 
quality of life of opioid dependence patients. It will also result in a reduction in social 
injustices that are as a result of opioid dependence while relieving family members and 
care givers the burden of monitoring the patient addicted to prescription opioids. 
Moreover, integration of the best available evidence will lead to a reduction in the 
economic, social, and criminal justice system burden placed by opioid dependence. 
Summary 
In this section, prescription opioid dependence has been identified as a substantial 
social and public health problem in the U.S. There are a broad range of treatment options 
including psychosocial and pharmacotherapeutic interventions that have been approved 
to treat opioid dependence. Nevertheless, there is a scarcity of reviews assessing the 
effectiveness of medication-assisted therapy interventions by nurse practitioner in 
reducing the problem of opioid misuse by adults seen in primary care. In addition, 
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existing literature has identified poor prescription practices in the management of patients 
suffering from opioid dependence.   
The purpose of this capstone DNP project was to synthesize the best available 
evidence on the effectiveness of medication-assisted therapy interventions in reducing the 
problem of opioid misuse and dependence by adults seen in primary care settings. The 
project will facilitate social change by promoting provision of evidence-based care 
leading to improved quality of life for opioid dependence patients as well as reductions in 
economic burden and contact with the criminal justice system. The next section will 
provide a review of specific and general literature and a discussion of the theoretical 
framework for this project.  
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Section 2:  Review of Scholarly Evidence 
Introduction 
The primary purpose of this scholarly project is to provide a systematic review of 
literature on the effectiveness of medication-assisted therapy interventions in reducing the 
problem of opioid dependence. Section 2 of the project scrutinizes general and specific 
literature on the problem of opioid dependence.  Specifically, the section discusses the 
current guidelines for management of opioid dependence, the role of advanced practice 
nurse practitioners in the management of opioid dependence and provides the theoretical 
framework to guide the review.  
Concepts, Models and Theories 
Health Belief Model  
The Becker’s (1974) health belief model (HBM) provided the theoretical 
framework for the review. The HBM is a psychological model that was developed to 
explain and predict health behaviors, especially regarding uptake of treatment and health 
promotion services (Maiman & Becker, 1974). The model attempts to demystify and 
predict human health related behaviors with a particular focus on their attitudes and 
beliefs. It was initially developed in the 1950s by Hochbaum, Kegels and Rosenstock in 
to explain why free screening programs provided by the U.S Public Health Services, 
particularly for tuberculosis, were not effective. Since then, the model has been used to 
examine a variety of short and long-lasting health behaviors such as sexual health risks 
and substance misuse and dependence.  
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The HBM is based on the premise that an individual will take a health related 
action if he or she: feels that it is possible to avoid the negative health condition, perceive 
themselves to be susceptible, believe that there would be serious repercussions, and 
believe that there would be some benefits as a result of change (DiClemente, Salazar, & 
Crosby, 2013). The model is composed of four major constructs including perceived 
susceptibility, perceived severity, perceived benefits, and perceived barriers. These 
concepts account individual’s readiness to change (Janz & Becker, 1984). 
Additional concepts include cues to action which refers to readiness and stimulate 
overt behavior and self-efficacy, which can be described as the confidence of an 
individual in his or her capability to perform a certain action (Franckowiak & Glick, 
2015). Having the confidence to taking action and integrating health behavior into the 
daily life of the patient are essential in the management of chronic health conditions. The 
efficacy of medical interventions is mostly dependent on the involvement of the patient in 
self-care activities. Opioid addiction is by definition, a chronic health condition, and the 
HBM has been used to study a variety of chronic health illnesses (Franckowiak & Glick, 
2015). 
Johns Hopkins Hierarchy of Evidence 
The Johns Hopkins Nursing EBP model will be used to rate the strength of the 
included evidence which may be judged by the type of the research design and quality of 
methods. The model has five levels and has been selected because it is designed to meet 
the needs of practicing nurse practitioners. Level I evidence refers to systematic reviews 
or meta-analysis of experimental studies, experimental studies or randomized controlled 
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trials (RCTs). Level II studies include quasiexperimental studies or systematic reviews of 
quasi-experimental studies. Level III refers to nonexperimental studies as well as 
systematic reviews with or without meta-analysis. The nonexperimental studies can be 
quantitative surveys or qualitative studies or their systematic reviews with or without 
meta-analysis. Level IV includes opinions of nationally recognised expert committees or 
consensus panels reviewing scientific evidence. Lastly, Level V is based on experiential 
evidence such as literature reviews, case reports, and quality improvement programs 
(Dearholt & Dang, 2012).         
Relevance to Nursing Practice 
This DNP project is of relevance to nursing practice because it provided an update 
on the effectiveness of medication-assisted interventions in improving outcomes in 
patients living with opioid dependence. Nursing practice has a reputation for promoting 
and enhancing the population health in the American society (Camicia et al., 2013). 
Unsafe prescription practices for opioid addicts lead to medication errors and undermine 
the reputation of nursing practice and, ultimately, the overall health care system (Ladd, 
Sweeney, Guarino, & Hoyt, 2017). Reviewing evidence on medication-assisted therapies 
can help registered nurse practitioners safely treat opioid addiction contributing to high 
quality and safe care (Boscarino et al., 2010; Kolodny et al., 2015; Volkow et al., 2014). 
A synthesis of best available practices can help address poor prescribing practices which 
are not evidence-based leading to improved outcomes of patients with opioid dependence 
problems. 
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The scope of practice for an APN allows for health assessment, diagnosis, 
treatment, health education, prescriptive authority, and preventative health care among 
more other responsibilities (Committee on the Robert Wood Johnson Foundation 
Initiative on the Future of Nursing, at the Institute of Medicine., Robert Wood Johnson 
Foundation., & Institute of Medicine, 2011). APNs have played a critical role in 
addressing shortage of health providers in rural and marginalized areas (Tierney et al., 
2015). A 2010 report by the Institute of Medicine (IOM) emphasized that nurse 
practitioners should be allowed to practice to the full extent of their training (IOM, 2011). 
Nevertheless, states have depicted disparities in granting legal autonomy of doctorally 
prepared nurse practitioners to practice and administer medications. Currently, 28 states 
do not allow APNs to prescribe buprenorphine unless they are working in collaboration 
with a physician who have a federal license to practice it (Pew Charitable Trusts, 2017). 
Therefore, most APNs are prohibited from practicing to their full potential in the 
provision of care to patients addicted to opioids despite evidence indicating that APNs 
provide safe and effective quality care (Newhouse et al., 2011).  
Advanced practice registered nurse’s narcotic prescriptive authority varies from 
one state to another with some states granting nurse practitioners broader prescriptive 
choice in comparison to others. For instance, Alabama and Florida have allowed APNs to 
administer only a limited selection of controlled medications while 19 other states have 
granted APNs permission to offer schedule II to IV drugs (Pew Charitable Trusts, 2017). 
The variation in prescription authority is questionable considering that the level of 
educational preparation and qualification for APNs is comparable across states and there 
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are national accreditation programs to ensure quality and consistency. The DNP 
candidate is a certified buprenorphine provider and has been approved for medication 
assisted therapy for patients addicted to prescription opioids.  
Existing Scholarship and Current State of Practice 
The prevalence of prescription abuse and misuse has greatly increased in the past 
two decades in the U.S. Currently, prescription opioids are the most frequently misused 
drugs, second only to cannabis, with about 1.9 million people trying them on an annual 
basis (Alderks, 2013). Data from the 2012 National Survey on Drug Use and Health point 
out that there are around 12.5 million Americans who misused prescription opioids, a 
substantial surge from 4.9 million reported in 1992 (Abuse, 2013). Cases of unintentional 
prescription opioid overdose increased by four times and cases of emergency department 
visits due to prescription opioid misuse increased by more than five times between 2000 
and 2010 (CDC, 2017).  
Some years before the 1990s, doctors were criticized for undertreating pain. 
However, there was a paradigm shift in the 1990s and pain came to be known as the 
“fifth vital sign” and general practitioners were encouraged to manage and address pain 
aggressively (Brady et al., 2015; Calcaterra, Glanz, & Binswanger, 2013). Later in 2012, 
the number of prescriptions written for opioids (259 million) was equivalent to the adult 
population of the U.S (Brady et al., 2015). Pain management is now at the center of the 
U.S. health care system with lawmakers and health practitioners attempting to minimize 
the adverse effects of the increased access to prescription opioids at the same time 
ensuring that pain is properly controlled.  
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Prescription Practices 
Opioids include both natural opiates and artificial congeners which are drugs that 
generate morphine like effects. They act principally on three types of receptor in the 
nervous system: delta, kappa, and mu (Tarter, Ammerman, & Ott, 2013). The mu 
receptor is basically responsible for the analgesic and euphoric features of opioids and 
attempts to generate an agent that produces analgesia without abuse potential have been 
futile. Most of the opioid analgesics currently in use are full mu agonists (hydrocodone, 
oxycodone, and morphine).  
Buprenorphine is a partial mu agonist and an antagonist at the kappa receptor and 
was approved by Food and Drug Administration (FDA) in 2002 for office-based 
management of opioid dependence (Veilleux et al., 2010). The drug can be used during 
maintenance and detoxification phases of opioid addiction. Considering that it is a partial 
agonist, there is reduced risk of overdose and its use in the long-term has not been 
associated with the development of severe withdrawal symptoms. Opioid antagonists 
such as nalmefene, naltrexone, and naloxone bind to opioid receptors and can be 
administered to prevent the effects of opioids (Kelly, Daley, & Douaihy, 2012).  
Opioid encompass many specific agents available in a broad range of 
preparations. Short-acting orally administered opioids including oxycodone, immediate-
release morphine, codeine, and hydromorphine usually have a quick onset of action (10-
60 minutes) and a short duration of action (2-4 hours) and are commonly used to manage 
acute breakthrough pain (Zacharoff et al., 2010). Long-acting or extended release opioids 
have a gentler onset of action (30-90 minutes) and a longer duration of action (4-72 
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hours) and are commonly used in the management of chronic pain (Wilson, 2015). It is 
recommended that providers should avoid administering more than one short-acting 
opioid concomitantly unless there are documented medical reasons (Nuckols et al., 2014).  
A combination of opioid and non-opioid analgesics is frequently used in the 
management of patients with moderate pain. Using a combination product when dosage 
intensification is needed raises the risks of adverse effects from the non-opioid co-
analgesic even if increasing the opioid dosage was an appropriate action. In such 
instances, the use of single agent formulations of opioid may be desirable (Kelly et al., 
2012; Nuckols et al., 2014).  
As concerns about opioid abuse and misuse have increased, attempts focused on 
developing abuse-deterrent and tamper-resistant opioid formulations have been made. A 
4:1 formulation of buprenorphine and naloxone designed for sublingual administration, 
marketed under the name Suboxone, is the most commonly used buprenorphine 
formulation (Brady et al., 2015). Sublingual naloxone will not provoke withdrawal; 
nevertheless, if Suboxone is administered intravenously, the naloxone will block the 
euphorigenic effects of buprenorphine and might trigger withdrawal (Tarter et al., 2013). 
Another deterrent technique is modifying the physical structure of tablets and 
incorporating compounds that make it difficult to liquefy, concentrate or otherwise 
transform the tablets. For instance, in 2014, FDA approved a new extended release 
oxycodone/ naloxone formulation with abuse deterrent properties (Wilson, 2015). Such 
preparations have been perceived as less vulnerable to abuse or misuse, though there is 
still potential for misuse.  
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The Office of National Drug Control Policy has put various strategies into place 
to deter opioid misuse and abuse. The strategies include educating health care providers 
as well as patients about the risks that are associated with abuse and misuse, promoting 
the Prescription Drug Monitoring Program, and supporting proper disposal of 
prescription drugs to avert diversion (Kuehn, 2014). On the other hand, best practice 
recommendations by Executive Office of the President of the US (2011) acknowledged 
the importance of balancing the benefits of opioids in pain management with the potential 
risks conferred, especially by chronic pain. The guidelines advocate for the universal 
application of risk mitigation strategies including mental health screening, conducting 
urine screening tests, treatment agreements, and dosing guidelines.   
Screening and Assessment 
Considering that it is a challenge to predict who will misuse opioid medications, 
universal risk assessment has been recommended. This means that all patients, including 
those not chronically receiving opioid analgesics on a daily basis should be assessed for 
the possibility of opioid abuse using validated tools prior to the commencement of opioid 
therapy (Meltzer et al., 2011). Positive results from the assessment should be followed up 
by a more rigorous assessment to collect further details. It is recommended that all 
patients on opioid therapy should receive education on safe usage and disposal regardless 
of their risk level (Barclay, Owens, & Blackhall, 2014).  
There are a number of validated tools that can be used by health care providers to 
weigh the risk of potential opioid misuse. It is essential that all patients undergo 
screening before commencing opioid therapy. Validated screening measures include the 
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Screener and Opioid Assessment for Patients with Pain and the Opioid Risk Tool (Passik, 
Kirsh, & Casper, 2008). The two instruments are suitable for identification of patients at 
risk of abuse or misuse before commencing opioid therapy. According to Butler et al. 
(2010), positive screening alone is inadequate to rule out opioid therapy, and positive 
results should be accompanied by a broader assessment such as clinical assessment and 
urine drug screening to determine the safety and the risk benefit ratio of the treatment.   
Treatment of Prescription Opioid use Disorders 
Though disorders due to prescription opioid are around four times more common 
compared to those of heroin use, therapy outcome research specific to prescription use 
disorders is scanty, and the scope to which therapeutic interventions developed to address 
the problem of heroin misuse can be effectively generalized to prescription opioid 
dependence remains to a large extent ambiguous (Brady et al., 2015; Holmes, 2012). In 
the absence of clear protocols to prescription opioid use disorders, most providers rely on 
their clinical knowledge or experience regarding treatment options for opioid use 
disorders.  
Treatment for opioid use disorders typically involve medically supervised 
withdrawal from the addicting drugs followed by maintenance with opioid substitution 
therapies (Calcaterra et al., 2013). Opioid substitution or replacement therapy involves 
administration of a longer acting opioid with less euphoric effects in an attempt to lessen 
craving and reduce withdrawal symptoms. Opioid substitution therapy mostly involves 
use of medication in the long-term, and in some cases, lifetime (Holmes, 2012). The two 
most commonly used substitution therapies are buprenorphine and methadone. Around 
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25% of patients with opioid use disorders have been administered with methadone 
maintenance therapy (MMT), making it one of the most frequently administered 
replacement therapy for opioid abuse and misuse disorders (Brady et al., 2015).  
Effectiveness rate for MMT ranges from 20% to 70%, and the outcomes are dose 
related, with individual variability in the effective dose (Mattick, Kimber, Breen, & 
Davoli, 2008). Lower dosages (20-40mg/day) have been found to be effective at 
subduing opioid withdrawal symptoms though they may not adequately reduce craving or 
block the effects of other opioids. Maintenance dosages are generally in the range of 70-
120 mg/day, though some patients require more than 120 mg/day for optimal therapeutic 
response (Mattick et al., 2008). The drug has been found to be effective in suppressing 
withdrawal and blocking the effects impact of other opioids. There is evidence that MMT 
improves treatment retention, reduces illicit opioid use, and is associated with reduced 
criminal activities related to opioid misuse (Brady et al., 2015).  
Buprenorphine was approved by FDA in 2002 as an office-based medication for 
prescription opioid dependence, and by 2012, 51% of opioid treatment programs was 
offering the drug (Wilson, 2015). The drug is a partial mu agonist; hence it is associated 
with less euphoria and sedating effects compared to methadone. It has also been shown to 
reduce withdrawal, hospital admission, morbidity, and mortality among individuals with 
opioid use dependence (Bell et al., 2009). Similar to MMT, buprenorphine therapy can be 
sustained for years (Rosenthal et al., 2016).  
 Lifetime or long-lasting opioid dependence therapy is not a preferable option for 
some people with opioid dependence. In such a scenario, a substitution therapy (mostly 
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Suboxone or buprenorphine) is steadily tapered and ultimately substituted with 
naltrexone to promote continuous opioid abstinence (Tarter et al., 2013). Naltrexone is an 
opioid antagonist that blocks the euphorigenic effects of opioids. While the efficacy of 
naltrexone has been traditionally hampered by low adherence rates, injection and implant 
options lately permitted by FDA have shown promising results (Kelly et al., 2012). The 
medication can be administered with ease, is not addictive, and has not been found to 
induce tolerance (Tarter et al., 2013). Nevertheless, considering that naltrexone 
minimizes opioid tolerance, it can raise the risk of having an overdose among individuals 
who return to illicit drug use. Mortality rates as a result of oral naltrexone are three to 
seven times higher than those associated with MMT (Brady et al., 2015). 
Local Background and Context 
As providers offering frontline care to patients with opioid dependence, advanced 
practice registered nurse practitioners are qualified and have a responsibility to play a 
leading role in monitoring and managing patients. It is essential for nurse practitioners to 
administer care that is backed by the best available evidence. Nurse practitioners at the 
practicum site have limited knowledge of administering medication-assisted therapies 
and are not confident in teaching patients about managing opioid dependence. The 
practicum site is a mental health facility with a mission of empowering its clients and 
families to cope with the challenges of various mental illnesses in an attempt to improve 
the quality of their lives. The vision of the mental health center is to become a center of 
excellence and a state leader in the field of mental health.  
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The community mental health center serves adults aged 16 and above with 
various mental challenges or symptoms of psychiatric illness. The mental health facility 
also deals with the issue of opioid dependence and has care providers who administer 
opioid medications. Collecting and analyzing data relating to the effectiveness of 
interventions aimed at addressing the problem of opioid dependence will assist the nurse 
practitioners at the practicum site by keeping them abreast of the changes in the field. The 
evidence can also be used to improve their knowledge and skills in management of opioid 
dependence thus reducing the impact of this problem on the individuals, families, society, 
and the health care system.  
Definitions of Terms 
This subsection defines terms frequently used in this paper. 
Advanced practice registered nurse: This is a nurse who has a master's, post-
master's certificate or doctoral of nursing educational level in nursing and had passed a 
national licensure examination for nurse practitioners (ANA, 2010). They are also 
referred to as advanced practice nurse practitioners (APNs), and both terms will be used 
in this paper. 
Opioid addiction/dependence: This is the inability of an individual to refrain from 
using opioid drugs regardless of the detrimental problems and no benefits attributable to 
their use (Edlund et al., 2014).  
Evidence-Based practice: Refers to the integration of patient values, clinical 
research, and best available evidence to make decisions regarding the provision of care to 
patients (Sackett, 1997).  
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Role of the DNP Student 
I am an advanced practice nurse with background in primary care and mental 
health and have worked for the current health center for more than a decade. I have taken 
a course in opioid dependence management and I am certified to administer medications 
and other interventions to manage this condition in an office-based setting. My 
motivation for this project was to review evidence on the effectiveness of interventions 
aimed at managing opioid dependence. 
 Opioids are commonly administered for management of severe pain and are 
commonly abused by patients. I have been dealing with opioid dependent patients and my 
optimism about this topic is that the evidence will improve nurse practitioners’ 
knowledge, skills, and confidence in the management of patients with this problem. 
Having interacted with opioid dependent patients and administered medications might 
have introduced bias in the review. To mitigate this bias, I followed the systematic and 
consistent procedures in the process of searching, retrieving, and reviewing the evidence 
presented in various studies before reaching a conclusion. I also did not have any 
competing interest or further information that need to be disclosed prior to conducting 
this review.    
Summary 
The prevalence of prescription abuse and misuse has skyrocketed in the past two 
decades in the US. Currently, prescription opioids are the most frequently misused drugs, 
second only to cannabis, with around 1.9 million people trying them on an annual basis. 
Though disorders due to prescription opioid are four times more common compared to 
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those of heroin use, therapy outcome research specific to prescription use disorders is 
limited. In the absence of clear protocols to prescription opioid use disorders, most 
providers rely on their clinical knowledge regarding treatment options for opioid use 
disorders. Therefore, there was a need to assess evidence from primary studies on the 
effectiveness of medication assisted therapies in management of prescription opioid 
dependence.  
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Section 3: Collection and Analysis of Evidence 
Introduction 
The purpose of the capstone project was to provide a systematic review of 
literature on the effectiveness of medication-assisted therapy interventions in reducing the 
problem of prescription opioid misuse by adults seen in primary care settings. It is 
important to have a clear understanding of the most effective and safe combination of 
medication assisted therapy to effectively treat opioid dependence. Section 3 offers a 
thorough description and justification of the methodology that will be used to carry out 
the proposed systematic review.  
Specifically, the section discusses the literature search techniques including the 
databases, search engines, key words, and inclusion and exclusion criteria. This is 
followed by a discussion of data analysis and quality assessment of the included journal 
articles. Although there are other approaches that can be used to carry out a secondary 
study, a systematic review approach was viewed as the most appropriate for the project of 
this nature to collect and analyze evidence of effectiveness of medication assisted therapy 
in treatment of opioid dependence.    
Practice-Focused Question 
Information is lacking about the effectiveness of nurse-led interventions aimed at 
reducing the problem of opioid dependence in mental health settings. A gap exists in 
practice when nurse practitioners or other health care providers administer interventions 
that are not supported by the best available evidence. Therefore, the purpose of the 
capstone project was to provide a systematic review of the literature on the effectiveness 
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of medication-assisted therapy interventions in reducing the problem of opioid misuse 
and dependence by adults seen in primary care settings. The question designed to guide 
this project was:  Do medication-assisted therapy interventions reduce the problem of 
opioid dependence and misuse by adults seen in primary care settings? The gap in 
practice was addressed by carrying out a systematic review of relevant evidence on the 
effectiveness of interventions aimed at reducing the problem of opioid dependence.  
Sources of Evidence 
The DNP project was completed using the systematic review of literature method 
of assessing the existing body of evidence on the effectiveness of medication assisted 
therapies in the treatment of opioid dependence. The review was carried out based on a 
revised version of the Cochrane systematic review handbook methodology. Steps 
identified by the handbook include designing the research questions, developing the 
literature search strategy, choosing and reviewing appropriate journal articles, gathering 
and evaluating data, followed by presentation and analysis of the findings (Higgins & 
Green, 2011). Data on the effectiveness of medication assisted interventions by nurse 
practitioners in the treatment of opioid dependence was searched and critically assessed 
while addressing the adequacy of the evidence and evaluating the outcomes.  
Godfrey and Harrison (2010) asserted that a systematic review of literature 
involves the analysis of the existing body of literature to establish the effectiveness of a 
given practice. Reviewing evidence systematically provides a predetermined plan to 
ensure consistency and minimize bias (Thomas, Ciliska, Dobbins, & Micucci, 2004), 
making the findings of a review to be more reliable compared to those of individual 
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studies. Nevertheless, the strength of the findings of a systematic review are good as that 
of the included primary studies (White & Waddington, 2012), suggesting that if the 
included studies contained flawed results; the conclusions reached on the review would 
not be credible.  
Published Outcomes and Research 
The systematic review was carried out following a critical review of the existing 
literature on the effectiveness of medication assisted therapy in treatment of opioid 
dependence. The literature search was carried through five electronic databases including 
PubMed, PsycINFO, EMBASE, CINAHL, and Cochrane Library. The electronic 
databases were selected because they contain peer-reviewed journal articles. According 
to Sampson et al. (2009), peer review process is an important step in validating the 
quality of research as a result of through the rigorous steps involved in the process. A 
supplementary search for grey literature was carried out through Google Scholar and 
organizational websites that offer services or carry out research involving people living 
with prescription opioid dependence.  
 Search terms related to psychosocial treatment, opioid dependence, addiction, 
medication assisted therapy, and effectiveness were used.  The search terms were 
broadened to identify appropriate journal articles. The searches were restricted to all 
fields including keywords, abstracts, and titles and will be restricted to studies involving 
human participants. A computer-assisted search through the various databases was 
carried out using the same search terms. This process was supplemented by performing a 
hand search to check the relevance of the included data. This is in line with Armstrong et 
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al.’s (2005) affirmations that hand searching is suitable tool in the search for evidence 
because it promotes the inclusive analysis of journal issues which may be in form of 
conference proceedings or case studies not published in major electronic databases.  
Boolean operators (AND, OR or NOT) were used in the literature search to 
combine search terms in an attempt to build a more focused search. Another advanced 
literature search technique that was used is truncation (e.g effect* to retrieve articles that 
included the word effect, effectiveness, and effective) to broaden the search process. 
Spelling variations and alternative words were also be taken into consideration so as to 
build a comprehensive search. The use of advanced search techniques has been supported 
by Ecker and Skelly (2010) who claimed that it makes it allows reviewers to identify 
appropriate journal articles with ease.  
Other major literature search techniques employed to carry out the review 
included citation searching and footnote chasing. Citation searching is a powerful 
technique that focuses on identifying articles citing known journal articles published 
previously (Kear & Colbert-Lewis, 2011). The technique was used to locate all articles 
that were the original sources on the research topic. A closely related literature search 
technique is footnote chasing and was used to locate relevant journal articles by carefully 
searching the bibliography of the identified papers. According to Tubré et al. (2011), 
footnote chasing tends to have a high precision considering that other researchers had 
reviewed the content of the materials and found them relevant to the current topic. 
Citation searching and footnote chasing literature search techniques were used to 
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supplement the literature search and possibly led to identification of up-to-date articles 
missed during the electronic database search.  
Evidence Generated for the Doctoral Project 
The literature search was to journal articles published from January 2011 to 2018. 
This is in accord with Booth, Sutton, and Papaioannou’s (2016) recommendation that 
reviewers should strive to include a realistic timeframe to act as a benchmark for deciding 
which studies should be included in a review. The search was restricted to studies 
available in English language and those involving human beings as participants. The 
participants should be adult patients receiving treatment of prescription opioid 
dependence from nurse practitioner or other health care providers. Outcomes of interest 
include opioid use, changes in symptoms, treatment retention, and attendance to 
counseling attendance.  
Eligible materials include articles evaluating the effectiveness of medication 
assisted therapy for treatment of prescription opioid dependence. In an event that an 
article presented a secondary analysis of data from an eligible study, the original report 
will be tracked and included in the review. Study designs that were considered included 
quasi-experimental, randomized controlled trials, case control, and cohort studies. Only 
articles available in full were included.  
The exclusion criteria included journal articles published before 2010, those 
involving participants receiving treatment for opioid dependence not as a result of 
prescription, and those published in any other language apart from English. The review 
also excluded non-empirical articles including editorials, literature reviews, and 
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commentaries. In addition, studies that failed to include sufficient control groups or 
whose study design did not allow for determination of the effectiveness of medication 
assisted therapies in combination with psychological treatment will be ineligible.  
Procedures 
Plonsky and Gass (2011) asserted that clinical trials are crucial resources that 
have an impact on decisions relating to management of chronic health conditions. Dixon-
Woods et al. (2007) added that assessing the quality of the research techniques used to 
conduct research is an essential strategy in the identification of the most robust evidence 
in health care. The claim has been reinforced by arguments (Thomas & Harden 2008) 
that the characteristic of the techniques used in conducting a primary study can indicate 
the level of validity and reliability of the findings of the study. Moreover, assessing the 
methods used to conduct research is essential because the differences in the quality of the 
methodology used can have a profound effect on the conclusions reached about the 
effectiveness of a particular intervention.  
Following a scrutiny of several reviews, Moher et al. (2009) found that 
randomized controlled trials that failed to offer essential details such as how the blinding 
of participants was done tended to report biased positive results compared to those that 
had outlined the procedures clearly. Assessing the quality of primary studies has attracted 
much debate in the recent past, with a number of tools being developed to assess the 
credibility of the included studies. 
The John Hopkins Evidence-based Practice model was used to evaluate the 
quality of the included evidence. The model has placed primary research into three levels 
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including level I (randomized controlled trials), level II (quasiexperimental) and level III 
which includes observational studies such as cohort studies and case series (Dearholt & 
Dang, 2012). Evidence from these study designs is rated on a three-point scale of high 
quality (Grade A), good quality (Grade B), and low quality (Grade C). High quality 
evidence comes from studies that had involved a representative and sufficient sample 
size, had adequate control, and produced findings that can be generalized. Good quality 
evidence comes from studies that had an adequate sample size, some control, and 
reasonably consistent results. Grade C evidence comes from studies that did not have 
representative and sufficient sample size for generalizability of the findings (Johns 
Hopkins Medicine, 2017) (See Appendix A).  
Protection of Human Subjects 
The review did not involve human participants directly hence it can be considered 
to be of low risk considering that ethical issues such as confidentiality and informed 
consent that arises with the collection of primary data will be minimal. As highlighted in 
the previous sub-section, the DNP candidate collected data regarding the effectiveness of 
medication-assisted therapies in the management of opioid dependence. Therefore, no 
human participants were required to take part or a direct medical record will be used to 
identify participants, hence no need to seek informed consent. Nevertheless, to ensure 
that the review complies with all ethical principles guiding research and fulfill the 
University’s DNP project, the project leader sought Institutional Review Board at Walden 
University, following the guidelines in the systematic review manual for approval.  
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Analysis and Synthesis 
The data were extracted by the reviewer together with a colleague. Any 
differences that emerged as a result of the differences in the extracted information were 
solved through a discussion. This is in line with Cronin, Ryan, and Coughlan’s (2008) 
recommendation that the data collection process should not be affected by any form of 
researcher prejudice. To accomplish this, Ramdhani, Ramdhani, and Amin (2014) 
recommended collecting data with the help of a colleague so as to not only reduce bias, 
but also save time on the data collection exercise.  
The review involved screening of the titles and abstracts of journal articles to 
determine if an article satisfied the inclusion criteria. The project leader extracted the data 
while her colleague cross-checked the data extraction forms for consistency, 
comprehensiveness, and accuracy. Characteristics of the study including authors, study 
design, participants, intervention, and main findings were collected to provide an 
overview of the included studies. This was followed by a critical analysis of the included 
materials to determine if there were confounding factors that may have led to biased 
results or conclusions. 
The evidence from eligible studies was rated using Johns Hopkins hierarchy of 
evidence. The hierarchy of evidence has three levels including level I for RCTs, level II 
for quasi-experimental and level III for observational studies (Johns Hopkins Medicine, 
2017).  Word processing software was used to store the references in a systematic 
manner. This is a valuable approach in processing and generating a list of reference list of 
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journals which allows duplicate references to be identified and deleted with ease (Cronin, 
Ryan, & Coughlan, 2008).  
The process for developing a systematic literature review begins with the 
development of a practice-focused question, acquisition of evidence, appraisal of the 
evidence, determining applicability, putting into practice, and assessing the outcomes 
(Godfrey & Harrison, 2010). The collection of the literature was completed through the 
search conducted through the electronic databases.  
Summary 
A clear understanding of the most effective interventions in the management of 
prescription opioid abuse and misuse is critical. As a result, the purpose of the capstone 
project was to provide a systematic review of literature on the effectiveness of 
medication-assisted therapy interventions in reducing the problem of prescription opioid 
misuse by adults seen in primary care settings. This section provided a discussion of the 
methodologies that was used to carry out the study. In summary, an exhaustive search 
was carried out across five major databases and data was collected, analyzed, and 
critiqued using the Johns Hopkins hierarchy of evidence model. Section 4 presents an 
evaluation of the findings of the systematic review.  
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Section 4: Findings and Recommendations 
Prescription opioid abuse and dependence is a major social and public health 
problem that has been escalating at a high rate in the U.S leading to high rates of 
overdose deaths and an increased number of patients seeking help for opioid dependence. 
The current problem of opioid dependence cannot be solved through the current punitive 
drug policies (Volkow, 2014). Nurse practitioners are ideally suited to carry out 
substance abuse interventions because of their knowledge to promote health. Therefore, 
the purpose of the capstone project was to provide a systematic review of the literature on 
the effectiveness of medication-assisted therapy interventions in reducing the problem of 
opioid misuse and dependence by adults seen in primary care settings.  
The sources of evidence were mostly peer-reviewed journals, both from nursing 
and other healthcare related disciplines. The review was carried out based on a revised 
version of the Cochrane Systematic Review Handbook methodology. Steps identified by 
the handbook include designing the research questions, developing the literature search 
strategy, choosing and reviewing appropriate journal articles, gathering and evaluating 
data, followed by presentation and analysis of the findings (Higgins & Green, 2011). 
Data on the effectiveness of medication-assisted interventions by nurse practitioners in 
the treatment of opioid dependence was searched and critically assessed while addressing 
the adequacy of the evidence and evaluating the outcomes. 
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Literature Search Results 
The literature search was carried out across CINAHL, Google Scholar, PubMed, 
and Cochrane library and it led to the identification of 912 studies, which after removing 
duplicates, 832 articles were left for the review. The titles and abstracts of the articles 
were reviewed to establish if they had satisfied the inclusion criteria. In total, 104 articles 
were reviewed in full, and 15 articles were identified as eligible for inclusion in this 
review. 14 were randomized controlled trials while only one study could be classified as 
quasi-experimental (see Figure 1).  
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
Figure 1. Selection process of the studies. 
 
After removing duplicates, 
832 studies were obtained  
After reading title and 
abstract 104 studies 
obtained  
Only 15 studies were 
included 
912 articles identified  
80 articles were excluded   
728 articles were 
excluded 
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The Johns Hopkins Nursing EBP model was used to rate the strength of the included 
evidence based on the type of the research design and quality of methods (Appendix B). 
The most commonly explored interventions were psychosocial interventions in 
conjunction with medications for opioid addiction. The most commonly investigated 
psychosocial intervention was cognitive behavioral therapy while the most frequently 
administered medication was methadone. The results of this review found moderate 
evidence to support the effectiveness of psychosocial interventions in conjunction with 
medications in the treatment of opioid dependence, although the strength of the efficacy 
varied from one study to another depending on the intervention provided. 
Study Outcomes and Limitations of Included Studies 
Most of the studies (n=15) indicated improvements in one or more of the outcome 
measures. Three of the included studies (Chen et al., 2013; Kidorf et al., 2013; Petry, 
Alessi, & Ledgerwood, 2012), focused on contingency management of opioid addiction, 
which is a type of treatment that provides rewards to people who demonstrate the desired 
behaviors such as reduced opioid misuse.  
Chen et al. (2013) sought to determine whether contingency management 
intervention implemented by the methadone maintenance treatment (MMT) clinic staff 
would improve adherence to treatment and reduce addiction to opioid misuse. A total of 
126 patients were randomly assigned to receive prize-based contingency management 
while 120 were placed in the MMT group which was the usual care. All the participants 
had to provide urine samples twice a week for a period of 12 weeks, and those in the 
contingency management group won awards after delivering morphine negative urine 
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samples and attend MMT. The retention rate and negative urine testing was 14.2% (p = 
0.010) and 10.7% (p < 0.001) higher in the contingency management group compared to 
the usual care group, respectively. In comparison to the usual treatment groups, those in 
the contingency group attended more statistically significant more days of therapy (p < 
0.01). The findings indicate that contingency management is an effective approach to 
reducing opioid misuse and encouraging attendance to treatment sessions for people 
addicted to opioids. 
Consistent findings were reported by Kidorf et al. (2013) randomized controlled 
trial that found participants in the contingency management group attended more 
psychiatric sessions each month (M = 5.71 vs. 2.44, p < .001) in comparison to the 
control group. The study involved 125 patients who were involved in the contingency 
management group and the control group. Participants in the two groups received the 
same schedule and magnitude of treatment which included daily methadone 
administration. Those in the contingency group received $25 per week upon attending all 
the sessions. Although the participants in the contingency group demonstrated greater 
attendance at psychiatric sessions, no significant differences were noted between the two 
groups in terms of substance use outcomes. Contrary to the findings of Chen et al. (2013), 
these researchers failed to find any evidence to support the effectiveness of contingency 
management in reducing substance use.   
Petry, Alessi, and Ledgerwood (2012) assessed the effectiveness of contingency 
management delivered by clinicians in a randomized controlled trial. There were 16 
healthcare providers who provided care to 130 patients placed in the contingency 
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management or the usual clinic care (MMT). Urine and breath samples were collected 
biweekly for a period of 12 weeks. Those in the contingency group had an opportunity to 
win prices of up to $100 for submitting urine samples negative of opioids and alcohol. 
Similar to Chen et al. (2013), those in the contingency management group remained in 
the study longer (9.5 weeks versus 6.7 weeks), abstained from opioid misuse for a longer 
duration (4.7 weeks versus 1.7 weeks), and submitted a higher percentage of negative 
urine samples (67.7% versus 29.4%) compared to those in methadone maintenance 
therapy alone. Nevertheless, the findings of the study ought to be interpreted in the 
context of its limitations. The differential rates of follow-up may have biased the long-
term outcome measures (most of the participants followed were in the intervention 
group). At the same time, the study was carried out by clinicians at methadone clinics and 
involved methadone dependent patients hence the findings may not be generalizable to 
other clinician and patient population.  
Cognitive-behavioral Therapy (CBT) 
Of the 19 studies included in this review, there were seven that assessed the 
effectiveness of CBT in combination with medication-assisted therapy. Kouimtsidis, 
Reynolds, Coulton, and Drummond (2012) multicenter randomized controlled trial 
evaluated the effectiveness of CBT in combination with MMT in the UK context. 
Participants were randomly assigned to the usual care group (MMT, n=31) or MMT plus 
CBT group (intervention, n=29). In addition to receiving the usual care, those in the 
intervention group took part in weekly individual CBT sessions for a period of six 
months. Although participants in the intervention group demonstrated statistically 
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significant improvements in positive expectancies of treatment, the findings showed no 
substantial between group mean differences in terms of abstinence rates, MMT 
compliance, psychological symptoms, and severity of psychosocial problems.  
Likewise, Moore et al. (2013) pilot study assessed the efficacy and feasibility of 
MMT as usual care (n=18) in combination with Therapeutic Interactive Voice Response 
(IVR) (n=18) for patients addicted to illegal opioids. IVR is a CBT-based therapeutic 
approach system that incorporates coping skills, goal setting, and self-monitoring. 
Consistent with the findings of Kouimtsidis et al. (2012), the trial did not find statistically 
significant differences between the groups in terms of substance use, study retention, 
MMT satisfaction, coping skills, or urinalysis-verified opioid abstinence. Those in the 
intervention group, however, were more likely to report opioid abstinence on the days the 
used the recovery line (p=0.01) in comparison to the days they did not. Participants were 
not followed-up, thus, making it hard to determine the impact of the intervention in the 
long-term. Besides, a small sample size was used hence the findings may not be 
generalizable to other settings.  
Pan et al. (2015) sought to determine whether CBT in conjunction with MMT 
therapy can reduce opiate misuse. The trial involved 240 opiate-dependent patients 
seeking care in community-based clinics and were randomly placed into the MMT groups 
(n=120) or the MMT plus CBT group (n=120). Compared to the standard care group, the 
CBR group had a higher percentage of opiate-negative urine tests at the end of three 
months (59% vs. 69%, p<0.05) and 63% vs. 73%, p<0.05) at the end of six months. The 
findings are contrary to those reported by Kouimtsidis et al. (2012) and Moore et al. 
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(2013) who did not find statistically significant improvements. Nevertheless, there was 
no follow-up in Pan et al. (2015) study thus it cannot be determined if the positive aspects 
persist in the long-term.  
Amini-Lari et al. (2017) evaluated the effectiveness of CBT in the treatment of 
opiate dependence in conjunction with MMT. A total of 118 participants who were 
regular users of opiates were randomly selected and placed in the usual care group (n = 
59) or the CBT plus MMT group (n = 59). CBT significantly reduced opiate use (p < 
0.01, d = 0.89) and the severity of opioid dependence (p < 0.01, d = 0.64) after one month 
of treatment. The findings indicate that the addition of the CBT component improves 
MMT effectiveness in reducing opiate dependence.  
Salehi and Alizadeh (2018) assessed the effectiveness of CBT and MMT in 
preventing opiate dependence based on cognitive-behavioral relapse prevention model. 
The study involved a total of 50 patients with opiate dependence and was randomly 
assigned into two groups. At the end of the six-month study period, 84% and 48% of the 
participants in the intervention and control groups showed abstinence from opioid misuse 
(P < 0.001). CBT was also associated with substantial improvement in self-efficacy of the 
participants in the intervention group.  
There were two included trials which explored the effectiveness of CBT in 
combination with buprenorphine treatment. The first one was by Fiellin et al. (2013) trial 
that sought to establish the effect of CBT in combination with naloxone/buprenorphine 
treatment for opioid dependence. The study involved 141 opioid-dependent patients in a 
primary care clinic. There were no statistically significant differences between the two 
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groups in terms of reductions in opioid misuse, although the two groups had a statistically 
significant pretest-posttest reduction in opioid misuse (p <0.001). It should be noted that 
the structured physician management usual care was more frequently administered than 
the standard practice for clinicians managing opioid dependence; thus, the care provided 
by clinicians could have created treatment outcomes that made it difficult to demonstrate 
the effectiveness of CBT. 
A similar study by Moore et al. (2012) explored the effect of two counseling 
sessions with two medication dispensing methods in patients receiving buprenorphine in 
primary care settings. In a three-month duration, opiate-dependent patients were assigned 
to physician management weekly buprenorphine therapy (n=28) and while 27 participants 
were placed in the buprenorphine and CBT group (intervention). There were no 
statistically significant differences between the two groups with regards to opioid 
abstinence, treatment retention, and participant satisfaction. Among those in the 
intervention group, CBT session attendance was positively associated with negative 
opioid urine (p <0.05). 
General Supportive Counseling  
Gu et al. (2013) sought to determine the effectiveness of adding psychosocial 
intervention to the usual clinic care in decreasing attrition and addressing non-attendance 
by the first-time newly admitted MMT users (n=288). Social workers provided 
counseling sessions based on the behavioral maintenance theory. Family members were 
involved, and misconceptions about MMT were addressed. In comparison to the control 
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group, the intervention group had a statistically significant lower risk of attrition and 
attended more days of MMT treatment (p <0.001) during the study period.   
A similar study by Weiss and Rao (2017) evaluated the effectiveness of opioid 
dependence counseling sessions in conjunction with buprenorphine (n=653). The trial 
failed to demonstrate any benefits of adding counseling to buprenorphine/naloxone 
medical management. Only around 7% of the patients achieved successful abstinence or 
near abstinence from opioids within an eight-week period of follow-up. Long-term 
follow-up findings were more encouraging with patients on opioid agonist treatment 
more likely to experience better outcomes. Although the study did not find sufficient 
evidence to support general counseling, this does not mean that patients should not be 
counseled. Some may do well with just medical management while others might do better 
upon receiving additional counseling.  
Other Psychosocial Interventions 
Brigham et al. (2014) assessed the effectiveness of a community reinforcement 
approach and family training in the context of buprenorphine treatment (n=104). The 14-
week trial involved opioid-dependent adults enrolled in a residential buprenorphine 
detoxification program and concerned significant others (CSO) to improve treatment and 
treatment retention. The intervention led to moderate but non-significant improvements 
in treatment retention compared to the control group. When CSO was a family member, 
there was a significant impact on treatment retention (p <0.01). Community 
reinforcement and family training is a promising intervention, but there is a need for 
further studies to confirm the findings. The study suffered from a series of limitations 
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such as small sample sizes, lack of power to determine the effectiveness of the 
intervention, and limited generalizability of the findings. 
The use of telephonic support systems to provide counseling in conjunction with 
buprenorphine care was assessed in Ruetsch, Tkacz, McPherson and Cacciola (2012) 
trial. A total of 1,426 patients were randomized to standard care (buprenorphine) or 
buprenorphine in conjunction with general counseling delivered through telephone calls. 
The study found that participants who accepted at least three intervention calls were more 
adherent to medication than those in the usual care group after one year (64.4% vs. 
56.1%, p <0.25). Patients who were compliant with treatment reported statistically 
significant lower scores of all the addiction severity index scores suggesting lower 
severity on addiction-related problems.  
Zhang et al. (2016) sought to explore the effects of standard care (MMT) in 
comparison to MMT in conjunction with psycho-education on opioid use, treatment 
adherence, and methadone use. The study involved a total of 492 MMT clients who had 
tested positive for morphine prior to intervention. The educational intervention focused 
on increasing methadone treatment literacy, promoting adherence to MMT, and goal 
setting. In the course of the intervention, positive urine morphine rates decreased by 
22.3% from 49.3% (p <0.001). In addition, the average daily methadone dosage increased 
to 72.6 mg from 63.0 (p <0.001) while the average number of days the participants were 
able to access MMT increased by 4.5% from 69.4% over a period of three months. The 
findings show that psycho-education in conjunction with MMT has the potential to 
promote adherence to treatment, reduce opioid misuse, and improve patient outcomes. 
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Nevertheless, the use of urine morphine test results was the main indicator of 
effectiveness, and participants could avoid using opioids prior to the urine tests thus 
generating a spurious intervention effect. The absence of a comparison group makes it 
hard to confidently determine the effectiveness of the intervention provided.   
Recommendations 
The primary focus of this review was on providing a systematic review of the 
literature on the efficacy of medication-assisted therapies in the management of the 
opioid dependence problems. The incremental benefit of adding psychosocial 
interventions to medically assisted treatments varied across studies with the psychosocial 
interventions provided. The findings of this review can be used to improve practice in the 
management of opioid dependence problem. The importance of developing best practices 
regarding management of opioid dependence is crucial. With the increasing number of 
U.S citizens struggling with opioid addiction and with the enactment of the Affordable 
Care Act, it is likely that the demand for management of opioid dependence will continue 
increasing.  
It is important to ascertain that physicians and advanced nurse practitioners 
understand the best outcomes that may be achieved once they manage opioid dependence 
through the various medication-assisted therapies. It is also critical that advanced nurse 
practitioners with authority to manage opioid dependence problems should be 
knowledgeable about various pharmacological approaches as well as psychosocial 
interventions and be able to use them in conjunction. A clear understanding of safety and 
efficacy is needed for them to manage opioid dependence problems successfully. 
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Appropriate use of medication and psychosocial interventions will also have implications 
for social change. It will enable people with opioid addiction problems to seek therapy 
and reduce the social injustices that are associated with addiction. In the future, the 
findings of this review can help reduce the criminal justice and health-care burdens 
incurred due to prescription opioid dependence. 
Strengths and Limitations 
A strength of this review is that it contributes to the existing body of knowledge 
by critically reviewing evidence from various primary studies about the effectiveness of 
medication-assisted therapies in addressing the problem of opioid dependence. In 
addition, most of the studies included in this review were randomized controlled trials 
which are considered as gold standard in research; hence the findings are less susceptible 
to bias due to randomization of the participants into the intervention or control groups. 
The review was affected by several limitations. The first one is that the literature 
search was limited to only those materials published in English language. The second 
limitation is that the researcher did not carry a formal assessment of the risk of bias as 
required in systematic reviews and meta-analysis, although risk of bias is likely to be low 
considering that the researcher collected data together with a colleague. Implications for 
future research is determining the specific forms of psychosocial interventions that are 
most effective when used alone or in combination with medications depending on the 
patient populations and treatment settings.   
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Section 5: Dissemination Plan 
Dissemination of scholarly findings marks the conclusion of doctoral nursing 
projects; it is essential to share the findings of an EBP project with other practitioners to 
improve healthcare practice (Zaccagnini & White, 2015). The outcomes of a project 
should be shared with the academic community, project stakeholders, and other 
practitioners working in similar settings.  Dissemination of the scholarly findings may be 
of benefit to other practitioners in similar settings. There are several approaches to 
disseminating project findings that can be used to disseminate the findings of this review.  
The first approach that will be used to disseminate the findings of this review is 
through the publication of the results. The DNP candidate will seek publication of the 
findings in a nursing journal that is that deals with addiction problems and other mental 
health issues. An abstract or a summary of the project in a peer-reviewed journal such as 
the Journal of Addictions Nursing would be an ideal approach. Publication in this journal 
would allow the results to reach nurse practitioners and other practitioners dealing with 
patients addicted to opioids. 
The second approach that can be employed to disseminate the findings is an oral 
presentation. This can be in the form of oral presentation or lectures in a given context 
(Edwards, 2015). I plan to create a professional poster and share the findings of the 
review with my colleagues in the workplace. I am also considering attending a regional 
conference on addiction problems, and this would provide an ideal platform to share the 
information regarding the findings of this project. Annual conference within my state can 
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provide an ideal opportunity to attract a large group of healthcare professionals providing 
care to patients who are opioid dependent.  
The crucial audience for the output of this project includes the project team at my 
workplace with whom I discussed the ideas within this project. Individuals that I 
discussed this project with included the nursing manager, site mentors, and nurse 
practitioners working at the hospital. Implementation of any practice change was beyond 
the scope of this review, but the findings could promote a reevaluation of the current 
practice to ensure that patients addicted to opioids benefit from the medication provided 
as well as appropriate cognitive and behavioral interventions. 
Analysis of Self 
The complexity of the contemporary healthcare environment requires nurse 
practitioners to be up to date with information and be in a position to address the gap 
between research evidence and practice. Based on the knowledge and skills that I have 
developed in the course of carrying out this review and my DNP course, I feel adequately 
prepared to perform my roles as an advanced nurse practitioner. In this subsection, I will 
provide an analysis of self as a practitioner, scholar, and project manager while drawing a 
connection between my experience in this project and long-term professional goals. 
As a Nurse Practitioner  
Translation of research findings into practice in the increasingly complex 
healthcare environment is the hallmark of scholarly nursing practice (Zaccagnini & 
White, 2015). Even though I was aware of the importance of evidence-based practice 
when commencing my DNP project, carrying out this review made me reflect on my 
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practice as an advanced nurse practitioner certified to manage patients with opioid 
addiction problems. I have been able to appreciate the role of behavioral and cognitive 
therapies in the management of opioid dependence problems and I will now be able to 
make the best clinical decisions based on the best available evidence.  
I have developed expertise throughout the DNP course and project that will help 
me function as a nurse leader. I aspire to become a nurse leader and promote adoption of 
best practices in the field of mental health. According to American Association of 
Colleges of Nursing (AACN) (2006), doctorally prepared nurse practitioners are expected 
to provide leadership for the adoption and implementation of evidence-based practices 
for the management of the various conditions. Throughout the DNP course and project, I 
have developed in various aspects of an advanced nurse practitioner; I have become 
equipped with knowledge and skills to review, appraise, and make use of research 
evidence to improve nursing practice. 
As a Scholar  
AACN (2018) defines nursing scholarship as activities that characteristically 
advance the teaching, research, and practice of nursing through rigorous processes. By 
carrying out the systematic review of the effectiveness of the various medication-assisted 
therapies in the management of opioid dependence, I have been able to contribute to 
scholarship in the field of addiction and substance misuse. I intend to further contribute to 
nursing scholarship through the distribution of the findings of this DNP project as 
outlined in the dissemination plan. 
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Carrying out this research has also improved my writing skills which are critical 
for an advanced nurse practitioner. I encountered several revisions, and this contributed 
to improvements in my writing skills. My writing skills have improved, and I have been 
able to acquire the status of a scholarly doctoral writer. I have also developed my critical 
analysis skills which I could have described as basic at the beginning of my doctoral 
project. The research involved reading research materials from different sources, 
critically appraising the information, and synthesizing the findings to reach meaningful 
conclusions.  
As a Project Developer  
A doctorally prepared nurse is expected to be in a position to identify and address 
a healthcare problem in their setting. As a nurse practitioner, I have encountered 
numerous patients addicted to opioids initially prescribed to manage non-cancer pain. 
Thousands of people are dying due to opioid dependence highlighting the need for 
effective interventions to reduce the addiction and mortality associated with opioid 
dependence. As a result, I carried out this literature review with an intention of 
identifying best practices in the management of opioid dependence.  
The process of completing this doctoral project was challenging but provided me 
with an opportunity to learn through experience. Carrying out a literature search and 
synthesizing the information took more time than I anticipated. In essence, time 
management was an issue, and I found myself lagging behind the project schedule. Upon 
reflecting on this challenge, I realized that I had allocated inadequate time to the various 
phases of this review. I had to revise my schedule to allow more time for various 
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activities such as literature search and analysis. I also had to work towards improving my 
personal discipline in following a set schedule by avoiding unnecessary interruptions and 
having specific, measurable, and realistic goals. The knowledge and the time 
management skills that I developed by carrying out this project have improved my 
confidence as a manager, and I will now be able to take part in identifying and 
developing evidence-based solutions to the current problems facing nursing practice. 
Summary 
Prescription opioid misuse and dependence has risen to epidemic proportions in 
the U.S. The problem has been associated with substantial morbidity and mortality rates 
besides inflicting huge social and economic costs as a result of lost productivity, health 
care costs, and expenses related to criminal justice. The purpose of this project was to 
provide a systematic review of literature on the effectiveness of medication-assisted 
therapy interventions in addressing the problem of prescription opioid misuse in health 
care settings. The most commonly explored interventions in the included studies were 
psychosocial interventions in conjunction with medications for opioid addiction. The 
most commonly investigated psychosocial intervention was cognitive behavioral therapy 
while the most frequently administered medication was methadone. The results of this 
review found moderate evidence to support the effectiveness of psychosocial 
interventions in conjunction with medications in the treatment of opioid dependence.  
It is important that advanced nurse practitioners with authority to manage opioid 
dependence problems are knowledgeable about various pharmacological approaches as 
well as psychosocial interventions and be able to use them in conjunction. A clear 
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understanding of safety and efficacy is needed for them to manage opioid dependence 
problems successfully. Appropriate use of medication and psychosocial interventions will 
also have implications for social change. It will enable people with opioid addiction 
problems to seek therapy and reduce the social injustices that are associated with 
addiction. In the future, the findings of this review can help reduce the criminal justice 
and health-care burdens incurred due to prescription opioid dependence. 
  
51 
 
References 
Abuse, S. (2013). Results from the 2012 National Survey on Drug Use and Health: 
Summary of national findings. In NSDUH Series H-46, HHS Publication No. 
(SMA) 13-4795. Substance Abuse and Mental Health Services Administration 
Rockville, MD. Retrieved from 
https://www.samhsa.gov/data/sites/default/files/NSDUHresults2012/NSDUHresu
lts2012.pdf 
Alderks, C. E. (2013). Trends in the Use of Methadone and Buprenorphine at Substance 
Abuse Treatment Facilities: 2003 to 2011. In: The CBHSQ Report. Rockville 
(MD): Substance Abuse and Mental Health Services Administration (US). 
Retrieved from: https://www.ncbi.nlm.nih.gov/books/NBK384659/ 
American Association of Colleges of Nursing. (2006). The essentials of doctoral 
education for advanced nursing practice. Washington, DC. Retrieved from: 
http://www.aacn.nche.edu 
Committee on the Robert Wood Johnson Foundation Initiative on the Future of Nursing, 
at the Institute of Medicine., Robert Wood Johnson Foundation., & Institute of 
Medicine (U.S.) (2011). The future of nursing: Leading change, advancing 
health. Washington, D.C: National Academies Press.  
American Association of Colleges of Nursing. (2018). Defining scholarship for the 
discipline of nursing. Retrieved from https://www.aacnnursing.org/News-
Information/Position-Statements-White-Papers/Defining-Scholarship 
52 
 
American Nurses Association. (2010). Nursing: Scope and standards of practice. Silver 
Spring, Md: American Nurses Association.  
American Nurse Practitioner Association. (2015). Nursing's role in addressing nation's 
opioid crisis. Retrieved 
https://www.nursingworld.org/~4ae212/globalassets/docs/ana/ana_nursings-
role-in-opioid-crisis_2016.pdf 
Amini-Lari, M., Alammehrjerdi, Z., Ameli, F., Joulaei, H., Daneshmand, R., Faramarzi, 
H., ... & Samadi, R. (2017). Cognitive-behavioral therapy for opiate users in 
methadone treatment: A multicenter randomized controlled trial. Iranian 
Journal of Psychiatry and Behavioral Sciences, 11(2).  
Armstrong, R., Jackson, N., Doyle, J., Waters, E., & Howes, F. (2005). It’s in your hands: 
The value of handsearching in conducting systematic reviews of public health 
interventions. Journal of public health, 27(4), 388-391. 
https://doi.org/10.1093/pubmed/fdi056 
Barclay, J. S., Owens, J. E., & Blackhall, L. J. (2014). Screening for substance abuse risk 
in cancer patients using the Opioid Risk Tool and urine drug screen. Supportive 
Care in Cancer, 22(7), 1883-1888. 
Bell, J., Trinh, L., Butler, B., Randall, D., & Rubin, G. (2009). Comparing retention in 
treatment and mortality in people after initial entry to methadone and 
buprenorphine treatment. Addiction, 104(7), 1193-1200. 
Booth, A., Sutton, A., & Papaioannou, D. (2016). Systematic approaches to a successful 
literature review. Sage. 
53 
 
Boscarino, J. A., Rukstalis, M., Hoffman, S. N., Han, J. J., Erlich, P. M., Gerhard, G. S., 
& Stewart, W. F. (2010). Risk factors for drug dependence among out‐patients on 
opioid therapy in a large US health‐care system. Addiction, 105(10), 1776-1782. 
http://dx.doi. org/10.1111/j.1360-0443.2010.03052.x 
Brady, K. T., McCauley, J. L., & Back, S. E. (2015). Prescription opioid misuse, abuse, 
and treatment in the United States: an update. American Journal of Psychiatry, 
173(1), 18-26. https://doi.org/10.1176/appi.ajp.2015.15020262 
Brigham, G. S., Slesnick, N., Winhusen, T. M., Lewis, D. F., Guo, X., & Somoza, E. 
(2014). A randomized pilot clinical trial to evaluate the efficacy of Community 
Reinforcement and Family Training for Treatment Retention (CRAFT-T) for 
improving outcomes for patients completing opioid detoxification. Drug and 
Alcohol Dependence, 138, 240–243. 
http://doi.org/10.1016/j.drugalcdep.2014.02.013 
Butler, S. F., Budman, S. H., Fanciullo, G. J., & Jamison, R. N. (2010). Cross validation 
of the Current Opioid Misuse Measure (COMM) to monitor chronic pain patients 
on opioid therapy. Clinical Journal of Pain, 26(9), 770. 
doi:10.1097/AJP.0b013e3181f195ba 
Calcaterra, S., Glanz, J., & Binswanger, I. A. (2013). National trends in pharmaceutical 
opioid related overdose deaths compared to other substance related overdose 
deaths: 1999–2009. Drug and alcohol dependence, 131(3), 263-270. 
54 
 
Camicia, M., Chamberlain, B., Finnie, R. R., Nalle, M., Lindeke, L. L., Lorenz, L., ... & 
Jones, T. (2013). The value of nursing care coordination: A white paper of the 
American Nurse Practitioner Association. Nursing Outlook, 61(6), 490-501. 
Center for Disease Control and Prevention. (2017). Prescription Opioid Overdose Data | 
Drug Overdose | CDC Injury Center. Retrieved from 
https://www.cdc.gov/drugoverdose/data/overdose.html 
Chen, W., Hong, Y., Zou, X., McLaughlin, M. M., Xia, Y., & Ling, L. (2013). 
Effectiveness of prize-based contingency management in a methadone 
maintenance program in China. Drug and alcohol dependence, 133(1), 270-274.  
Crane, E. H. (2013). Highlights of the 2011 Drug Abuse Warning Network (DAWN) 
findings on drug-related emergency department visits. 
Cronin, P., Ryan, F., & Coughlan, M. (2008). Undertaking a literature review: a step-by-
step approach. British journal of nursing, 17(1), 38-43. 
Dearholt, S., & Dang, D. (2012). Johns Hopkins nursing evidence-based practice: models 
and guidelines. 2nd ed. Indianapolis, IN: Sigma Theta Tau International. 
DiClemente, R. J., Salazar, L. F., & Crosby, R. A. (2013). Health behavior theory for 
public health. Jones & Bartlett Publishers. 
Dixon-Woods, M., Sutton, A., Shaw, R., Miller, T., Smith, J., Young, B., ... & Jones, D. 
(2007). Appraising qualitative research for inclusion in systematic reviews: a 
quantitative and qualitative comparison of three methods. Journal of health 
services research & policy, 12(1), 42-47. 
55 
 
Ecker, E. D., & Skelly, A. C. (2010). Conducting a winning literature search. Evidence-
Based Spine-Care Journal, 1(1), 9–14. http://doi.org/10.1055/s-0028-1100887 
Edlund, M. J., Martin, B. C., Russo, J. E., Devries, A., Braden, J. B., & Sullivan, M. D. 
(2014). The role of opioid prescription in incident opioid abuse and dependence 
among individuals with chronic non-cancer pain: the role of opioid prescription. 
The Clinical journal of pain, 30(7), 557. 
Edwards, D. J. (2015). Dissemination of Research Results: On the Path to Practice 
Change. The Canadian Journal of Hospital Pharmacy, 68(6), 465–469. 
Executive Office of the President of the US. (2011). Epidemic: Responding to America's 
prescription drug abuse crisis. Washington, D.C.: Executive Office of the 
President of the United States, Office of National Drug Control Policy. Retrieved 
from https://www.ncjrs.gov/App/Publications/abstract.aspx?ID=256103 
Fiellin, D. A., Barry, D. T., Sullivan, L. E., Cutter, C. J., Moore, B. A., O’Connor, P. G., 
& Schottenfeld, R. S. (2013). A Randomized Trial of Cognitive Behavioral 
Therapy in Primary Care-based Buprenorphine. The American Journal of 
Medicine, 126(1), 74.e11–74.e17. http://doi.org/10.1016/j.amjmed.2012.07.005  
Florence, C. S., Zhou, C., Luo, F., & Xu, L. (2016). The economic burden of prescription 
opioid overdose, abuse, and dependence in the United States, 2013. Medical 
care, 54(10), 901-906. 
Franckowiak, B. A., & Glick, D. F. (2015). The effect of self-efficacy on treatment. 
Journal of addictions nursing, 26(2), 62-70. 
DOI:10.1097/JAN.0000000000000073 
56 
 
Godfrey, C., & Harrison, M. B. (2010). Systematic review resource package. The Joanna 
Briggs Institute method for systematic review research quick reference guide. 
Kingston, ON: Queen's Joanna Briggs Collaboration. 
Hedden, S. L. (2015). Behavioral health trends in the United States: results from the 
2014 National Survey on Drug Use and Health. Substance Abuse and Mental 
Health Services Administration, Department of Heath & Human Services. 
Higgins, J. P., & Green, S. (Eds.). (2011). Cochrane handbook for systematic reviews of 
interventions (Vol. 4). Chichester, West Sussex; John Wiley & Sons. 
Holmes, D. (2012). Prescription drug addiction: the treatment challenge. The Lancet, 
379(9810), 17-18. 
Hser, Y. I., Evans, E., Grella, C., Ling, W., & Anglin, D. (2015). Long-term course of 
opioid addiction. Harvard review of psychiatry, 23(2), 76-89. 
Institute of Medicine (US). Committee on the Robert Wood Johnson Foundation 
Initiative on the Future of Nursing. (2011). The future of nursing: Leading 
change, advancing health. Washington, DC: National Academies Press. 
Janz, N. K., & Becker, M. H. (1984). The health belief model: A decade later. Health 
Education Quarterly, 11(1), 1-47. 
Johns Hopkins Medicine. (2017). EBP Models and Tools. Retrieved from 
http://www.hopkinsmedicine.org/evidence-based-practice/jhn_ebp.html 
Kear, R., & Colbert-Lewis, D. (2011). Citation searching and bibliometric measures: 
Resources for ranking and tracking. College & research libraries news, 72(8), 
470-474. 
57 
 
Kelly, T. M., Daley, D. C., & Douaihy, A. B. (2012). Treatment of substance abusing 
patients with comorbid psychiatric disorders. Addictive behaviors, 37(1), 11-24. 
Kidorf, M., Brooner, R. K., Gandotra, N., Antoine, D., King, V. L., Peirce, J., & 
Ghazarian, S. (2013). Reinforcing Integrated Psychiatric Service Attendance in 
an Opioid-Agonist Program: A Randomized and Controlled Trial. Drug and 
Alcohol Dependence, 133(1), 30–36. 
http://doi.org/10.1016/j.drugalcdep.2013.06.005  
Kolodny, A., Courtwright, D. T., Hwang, C. S., Kreiner, P., Eadie, J. L., Clark, T. W., & 
Alexander, G. C. (2015). The prescription opioid and heroin crisis: a public 
health approach to an epidemic of addiction. Annual review of public health, 36, 
559-574. 
Kouimtsidis, C., Reynolds, M., Coulton, S., & Drummond, C. (2012). How does 
cognitive behavior therapy work with opioid-dependent clients? Results of the 
UKCBTMM study. Drugs: education, prevention, and policy, 19(3), 253-258.  
Kuehn, B. M. (2014). CDC: major disparities in opioid prescribing among states: some 
states crack down on excess prescribing. Jama, 312(7), 684-686. 
http://doi.10.1001/jama.2014.9253 
Ladd, E., Sweeney, C. F., Guarino, A., & Hoyt, A. (2017). Opioid Prescribing by Nurse 
Practitioners in Medicare Part D: Impact of State Scope of Practice Legislation. 
Medical Care Research and Review, 1077558717725604. 
58 
 
Lock, C. A., Kaner, E., Heather, N., Doughty, J., Crawshaw, A., McNamee, P., ... & 
Pearson, P. (2006). Effectiveness of nurse‐led brief alcohol intervention: a cluster 
randomized controlled trial. Journal of advanced nursing, 54(4), 426-439. 
Maiman, L. A., & Becker, M. H. (1974). The health belief model: Origins and correlates 
in psychological theory. Health Education Monographs, 2(4), 336-353. 
Mattick, R. P., Kimber, J., Breen, C., & Davoli, M. (2008). Buprenorphine maintenance 
versus placebo or methadone maintenance for opioid dependence. Cochrane 
Database Syst Rev, 2(2). 
Melnyk, B. M., & Fineout-Overholt, E. (2011). Evidence-based practice in nursing & 
healthcare: A guide to best practice. Philadelphia: Wolters Kluwer/Lippincott 
Williams & Wilkins.  
Meltzer, E. C., Rybin, D., Saitz, R., Samet, J. H., Schwartz, S. L., Butler, S. F., & 
Liebschutz, J. M. (2010). Identifying prescription opioid use disorder in primary 
care: diagnostic characteristics of the Current Opioid Misuse Measure (COMM). 
Pain, 152(2), 397-402.  
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & PRISMA Group. (2010). Preferred 
reporting items for systematic reviews and meta-analyses: the PRISMA 
statement. International Journal of Surgery, 8(5), 336-341. 
Moore, B. A., Barry, D. T., Sullivan, L. E., O’Connor, P. G., Cutter, C. J., Schottenfeld, 
R. S., & Fiellin, D. A. (2012). Counseling and directly observed medication for 
primary care buprenorphine/naloxone maintenance: A pilot study. Journal of 
59 
 
Addiction Medicine, 6(3), 205–211. 
http://doi.org/10.1097/ADM.0b013e3182596492  
Moore, B. A., Fazzino, T., Barry, D. T., Fiellin, D. A., Cutter, C. J., Schottenfeld, R. S., 
& Ball, S. A. (2013). The Recovery Line: A pilot trial of automated, telephone-
based treatment for continued drug use in methadone maintenance. Journal of 
Substance Abuse Treatment, 45(1), 63–69. 
http://doi.org/10.1016/j.jsat.2012.12.011  
National Institute on Drug Abuse. (2017). Overdose Death Rates | National Institute on 
Drug Abuse (NIDA). Retrieved from https://www.drugabuse.gov/related-
topics/trends-statistics/overdose-death-rates 
Newhouse, R. P., Stanik-Hutt, J., White, K. M., Johantgen, M., Bass, E. B., Zangaro, G., 
& Weiner, J. P. (2011). Advanced practice nurse outcomes 1990-2008: A 
systematic review. Nursing Economics, 29(5), 230. 
Nuckols, T. K., Anderson, L., Popescu, I., Diamant, A. L., Doyle, B., Di Capua, P., & 
Chou, R. (2014). Opioid prescribing: A systematic review and critical appraisal 
of guidelines for chronic pain. Annals of Internal Medicine, 160(1), 38-47. 
Nyamathi, A. M., Sinha, K., Greengold, B., Marfisee, M., Khalilifard, F., Cohen, A., & 
Leake, B. (2011). Effectiveness of intervention on improvement of drug use 
among methadone maintained adults. Journal of Addictive Diseases, 30(1), 6–16. 
http://doi.org/10.1080/10550887.2010.531669 
60 
 
Pan, S., Jiang, H., Du, J., Chen, H., Li, Z., Ling, W., & Zhao, M. (2015). Efficacy of 
cognitive behavioral therapy on opiate use and retention in methadone 
maintenance treatment in China: A randomized trial. PloS one, 10(6), e0127598. 
Passik, S. D., Kirsh, K. L., & Casper, D. (2008). Addiction-related assessment tools and 
pain management: instruments for screening, treatment planning, and monitoring 
compliance. Pain Medicine, 9(suppl_2), S145-S166. 
Petry, N. M., Alessi, S. M., & Ledgerwood, D. M. (2012). A randomized trial of 
contingency management delivered by community therapists. Journal of 
Consulting and Clinical Psychology, 80(2), 286–298. 
http://doi.org/10.1037/a0026826 (Petry, Alessi, & Ledgerwood, 2012). 
Plonsky, L., & Gass, S. (2011). Quantitative research methods, study quality, and 
outcomes: The case of interaction research. Language Learning, 61(2), 325-366. 
Ramdhani, A., Ramdhani, M. A., & Amin, A. S. (2014). Writing a Literature Review 
Research Paper: A step-by-step approach. International Journal of Basic and 
Applied Science, 3(1), 47-56. 
Rosenthal, R. N., Lofwall, M. R., Kim, S., Chen, M., Beebe, K. L., & Vocci, F. J. (2016). 
Effect of buprenorphine implants on illicit opioid use among abstinent adults 
with opioid dependence treated with sublingual buprenorphine: a randomized 
clinical trial. Jama, 316(3), 282-290. 
Rudd, R. A., Aleshire, N., Zibbell, J. E., & Matthew Gladden, R. (2016). Increases in 
drug and opioid overdose deaths—United States, 2000–2014. American Journal 
of Transplantation, 16(4), 1323-1327. 
61 
 
Ruetsch, C., Tkacz, J., McPherson, T. L., & Cacciola, J. (2012). The effect of telephonic 
patient support on treatment for opioid dependence: outcomes at one year follow-
up. Addictive Behaviors, 37(5), 686-689. 
Sackett, D. L. (1997). Evidence-based medicine: How to practice and teach EBM. 
Edinburgh: Elsevier/Churchill Livingstone.  
Salehi, L., & Alizadeh, L. (2018). Efficacy of a Cognitive-Behavioral Relapse Prevention 
Model in the Treatment of Opioid Dependence in Iran: A Randomized Clinical 
Trial. Shiraz E-Medical Journal, 19(5).  
Gu, J., Lau, J. T., Xu, H., Zhong, Y., Hao, Y., Zhao, Y. ... & Ling, W. (2013). A 
randomized controlled trial to evaluate the relative efficacy of the addition of a 
psycho-social intervention to standard-of-care services in reducing attrition and 
improving attendance among first-time users of methadone maintenance 
treatment in China. AIDS and Behavior, 17(6), 2002-2010. 
Sampson, M., McGowan, J., Cogo, E., Grimshaw, J., Moher, D., & Lefebvre, C. (2009). 
An evidence-based practice guideline for the peer review of electronic search 
strategies. Journal of clinical epidemiology, 62(9), 944-952. 
SAMSHSA (2013). Results from the 2012 National Survey on Drug Use and Health: 
Summary of National Findings, NSDUH Series H-46, HHS Publication No. 
(SMA) 13-4795. Rockville, MD: Substance Abuse and Mental Health Services 
Administration.  
Solomon, D. (2016). Safer prescribing for opioid dependence. Nursing Times; 112: online 
issue 12, 5-8. Retrieved from https://www.nursingtimes.net/clinical-
62 
 
archive/substance-misuse/safer-prescribing-for-opioid-
dependence/7011010.article 
Sperhac, A. M., & Clinton, P. (2008). The essentials of doctoral education for advanced 
nursing practice. Journal of Pediatric Health Care, 3(22), 146-151. 
Suryaprasad, A. G., White, J. Z., Xu, F., Eichler, B. A., Hamilton, J., Patel, A., ... & 
Macomber, K. (2014). Emerging epidemic of hepatitis C virus infections among 
young nonurban persons who inject drugs in the United States, 2006–2012. 
Clinical Infectious Diseases, 59(10), 1411-1419. 
Tarter, R. E., Ammerman, R., & Ott, P. J. (Eds.). (2013). Handbook of substance abuse: 
Neurobehavioral pharmacology. New York, NY, US: Plenum Press. 
http://dx.doi.org/10.1007/978-1-4757-2913-9 
The Pew Charitable Trusts. (2017). Nurse licensing laws block treatment for opioid 
addiction. Retrieved from http://www.pewtrusts.org/en/research-and-
analysis/blogs/stateline/2017/04/21/nurse-licensing-laws-block-treatment-for-
opioid-addiction 
Thomas, B. H., Ciliska, D., Dobbins, M., & Micucci, S. (2004). A process for 
systematically reviewing the literature: Providing the research evidence for 
public health nursing interventions. Worldviews on Evidence‐Based Nursing, 
1(3), 176-184. 
Thomas, J., & Harden, A. (2008). Methods for the thematic synthesis of qualitative 
research in systematic reviews. BMC Medical Research Methodology, 8(1), 45. 
63 
 
Tierney, M., Finnell, D. S., Naegle, M. A., LaBelle, C., & Gordon, A. J. (2015). 
Advanced practice nurse practitioner: increasing access to opioid treatment by 
expanding the pool of qualified buprenorphine prescribers. Substance Abuse, 
36:4, 389-392, http://dx.doi.org/10.1080/08897077.2015.1101733 
Tubré, T. C., Bly, P. R., Edwards, B. D., Pritchard, R. D., & Simoneaux, S. (2011). 
Building a better literature review: References and information sources for IO 
psychology. The Industrial-Organizational Psychologist, 38(4), 55-59. 
Veilleux, J. C., Colvin, P. J., Anderson, J., York, C., & Heinz, A. J. (2010). A review of 
opioid dependence treatment: pharmacological and psychosocial interventions to 
treat opioid addiction. Clinical Psychology Review, 30(2), 155-166. 
DOI:10.1016/j.cpr.2009.10.006 
Volkow, N. D. (2014). America’s addiction to opioids: Heroin and prescription drug 
abuse. Senate Caucus on International Narcotics Control. Washington, DC. 
Volkow, N. D., Frieden, T. R., Hyde, P. S., & Cha, S. S. (2014). Medication-assisted 
therapies-tackling the opioid-overdose epidemic. New England Journal of 
Medicine, 370(22), 2063-2066. 
Weiss, R. D., & Rao, V. (2017). The prescription opioid addiction treatment study: what 
have we learned. Drug and Alcohol Dependence, 173, S48-S54. 
White, H., & Waddington, H. (2012). Why do we care about evidence synthesis? An 
introduction to the special issue on systematic reviews. Journal of Development 
Effectiveness, 4(3), 351-358. 
64 
 
Wilson, P.R. (2015). Responsible Opioid Prescribing. A Clinician's Guide, Second 
Edition Revised & Expanded. Pain Medicine. 16. 1027-1028. 
10.1111/pme.12711. 
Zaccagnini, M., & White, K. (2015). The doctor of nursing practice essentials: A new 
model for advanced practice nursing. Sudbury, Mass: Jones and Bartlett 
Publishers.  
Zacharoff, K. L., McCarberg, B. H., Reisner, L., & Venuti, S. W. (2010). Managing 
Chronic Pain with Opioids in Primary Care. Newton, Mass, Inflexxion Health 
Series. 
Zhang, B., Cai, T., Yan, Z., Mburu, G., Wang, B., & Yang, L. (2016). Impact of blended 
treatment literacy and psychoeducation on methadone maintenance treatment 
outcomes in Yunnan, China. Harm ReductionJournal, 13(1), 8. 
https://doi.org/10.1186/s12954-016-0097-y 
  
65 
 
Appendix A: Systematic Review Matrix 
Citatio
n 
Country  Objective  Research Design 
(include tools) and 
Sample Size  
Key Findings Strengths and 
limitations  
Level 
of 
Eviden
ce 
Amini-
Lari et 
al. 
(2017) 
 
Iran To evaluate the 
effectiveness of 
CBT in the 
treatment of 
regular opiate 
use on a stable 
methadone dose 
Multicenter RCT 
Valid and reliable 
tool (Severity of 
Dependence Scale)  
118 patients who 
were regular opiate 
users were selected 
Control 59, 
Intervention 59  
 
CBT significantly 
reduced opiate use (z = 
3.73, P = 0.01, d = 
0.89) and the severity 
of opiate dependence 
(z = 7.36, P = 0.01, d = 
0.64) after four weeks 
of treatment 
Strengths 
No participant attrition 
Limitation 
Only one follow-up  
95% of the participants 
were men, hence findings 
largely applies to men 
Participants not blinded  
Level 1, 
Quality 
B 
 
Brigha
m et al. 
(2014) 
USA To test the 
efficacy of a new 
psychosocial 
intervention 
(CRAFT-T) in 
comparison to 
usual treatment  
RCT 
52 adult participants 
with prescription 
opioid dependence 
 
CRAFT-T led to 
moderate effect on 
treatment retention (p 
= 0.058,). There were 
large and statistically 
significant effects on 
treatment retention 
when family members 
were involved (p < 
0.01).  
Strengths 
Randomization reduces 
bias in the selection 
process 
No missing data on the 
primary outcome measure 
Limitations 
Small sample size: lack of 
generalizability, lack of 
power to evaluate 
therapist effects and to 
fully evaluate the effects 
of CSO relationship type, 
and possibly distorted 
estimates of effect sizes 
Level 1, 
Quality 
B 
 
Chen et 
al. 
(2013) 
 
China  To assess the 
impact of 
contingency 
management 
intervention 
implemented by 
MMT clinic on 
treatment 
attendance and 
drug abstinence. 
 
RCT, 126 
participants 
received 
contingency 
management (CM), 
while 120 received 
usual treatment 
(UT), 
Zung Self-rating 
Depression Scale 
was used  
 
The retention rate and 
negative urine testing 
rate were 14.2% 
(P=0.010) and 10.7% 
(P<0.001) higher in the 
CM group compared to 
usual care group, 
respectively. In 
comparison to UT, CM 
group missed an 
average of 7.3 fewer 
(p=0.008) and were 
1.91 (95% CI: 1.53-
2.39) times more likely 
to submit a negative 
urine sample. 
Strengths 
Randomization eliminates 
bias in the selection 
process 
Sample selected from 
different part of the city 
hence findings are 
representative  
Limitations  
Lower frequency of urine 
monitoring (twice a week 
while past studies 
monitored more than 3 
times a week) 
 
Level 1, 
Quality 
A 
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Fiellin 
et al. 
(2013) 
USA To assess the 
effects of CBT 
on outcomes in 
primary care, 
office-based 
buprenorphine/n
aloxone 
treatment of 
opioid 
dependence 
24-week 
randomized clinical 
trial 
141 opioid-
dependent patients 
Patients were 
randomized to UT 
or UT + CBT 
 
The 2 treatments had 
similar effectiveness in 
reduction of self-
reported frequency of 
opioid use, from 5.3 
days per week (95% 
confidence interval, 
5.1–5.5) at baseline to 
0.4 (95% confidence 
interval, 0.1–0.6) for 
the second half of 
maintenance (P<.001 
for the comparisons of 
induction and 
maintenance with 
baseline), with no 
differences between 
the 2 groups (P=.96) or 
between the treatments 
over time (P=.44). 
No selection bias due to 
randomization  
An appropriate sample 
size hence findings 
generalizability 
Limitations 
Eligibility criteria could 
have excluded people 
who were less likely to 
experience significant 
improvements  
 
Level 1, 
Quality 
B 
 
Gu et 
al. 
(2013) 
 
China  To investigate 
the relative 
efficacy of 
adding a psycho-
social 
intervention to 
the usual care in 
decreasing 
attrition and non-
attendance 
among first-time 
newly admitted 
MMT users 
 
RCT, 142 
participants in 
intervention group, 
146 in the usual 
care group  
 
Compared to the usual 
care group, those in the 
intervention group 
showed significantly 
lower risk of attrition 
(HR =0.55, 95 % CI 
0.39-0.80), lower 
estimated probability 
of attrition after one 
year (0.35 vs. 0.55) 
 
Strengths 
A relatively large sample 
used 
Randomization reduces 
selection bias 
Limitations 
Study only carried out in 
one city 
No blinding of 
participants or healthcare 
providers 
Level 1, 
Quality 
B 
 
Kidorf 
et al. 
(2013) 
 
USA To assess the 
effectiveness of 
contingency 
management to 
enhance the use 
of psychiatric 
services located 
and integrated 
within a 
community-
based MMT 
program.  
RCT, 125 Opioid-
dependent 
outpatients took 
part 
Participants met 
DSM-IV-R criteria 
for psychiatric 
diagnosis 
Self-Report 
Measure of 
Medication 
Adherence was 
used 
Participants in the 
intervention group 
attended more overall 
psychiatric sessions at 
the first month ((M = 
7.53 vs. 3.97, p < .001, 
month 2 (M = 6.31 vs. 
2.81, p < .001, and 
month 3 (M = 5.71 vs. 
2.44, p < .001). Similar 
rates of drug-positive 
urine samples. No 
differences in study 
Project was associated 
with significant 
improvements in 
attendance of the 
treatment sessions  
Limitation 
Concerns regarding 
feasibility due to high 
cost of attendance 
incentives ($165) 
Study did not control for 
prescription practices, 
which may have 
Level 1, 
B 
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retention were 
observed. 
introduced unknown error 
variance 
Kouimt
sidis et 
al. 
(2012) 
 
UK To investigate 
the effectiveness 
and cost-
effectiveness of 
CBT in MMT 
for opioid 
dependent 
patients  
 
RCT, 60 patients 
 
No substantial between 
groups mean 
differences in terms of 
abstinence rates, MMT 
compliance, 
psychological 
symptoms, and 
severity of 
psychosocial 
problems.  
Strength 
Randomization 
Limitations 
Small sample size 
 
Level 1, 
C 
 
Moore 
et al. 
(2012) 
 
USA To investigate 
the impact of 
two counseling 
intensities in 
patients 
receiving 
buprenorphine in 
primary care  
RCT 
Intervention group, 
28 UT + CBT 
Control, 27 UT 
Self-reported opioid 
abstinence 
questionnaire used 
Analyses adjusting for 
baseline characteristics 
showed no significant 
differences between 
groups on retention or 
drug use based on self-
report or urines. 
 
Strength 
Randomization reducing 
selection bias 
Limitation 
Small sample size lacking 
statistical power  
Lack of follow-up after 
intervention 
Level I, 
B 
 
Moore 
et al. 
(2013) 
 
USA To assess the 
feasibility, 
acceptability, 
and efficacy of 
interactive voice 
response for 
patients 
receiving MMT 
 
RCT, 36 patients, 
UT or recovery line 
+ UT 
 
Patients were more 
likely to report 
abstinence for opioids 
and cocaine on days 
they used the Recovery 
Line (p = .01) than 
those they did not. 
 
Randomization of 
participants 
Limitations 
Small sample size 
There were marginally 
significant differences on 
baseline variables such as 
gender 
Level I, 
C  
 
Pan et 
al., 
2015 
 
China To test whether 
CBT in 
conjunction with 
MMT improves 
treatment 
retention and 
decreases opiate 
use 
RCT, 240 opiate 
dependent patients, 
CBT=120 patients, 
standard 120  
Addiction Severity 
Index (ASI) scale 
used  
 
Compared to control 
group, intervention 
group had a higher 
proportion of opiate-
negative urine tests  
At both 12 and 26 
weeks, CBT group 
exhibited more 
Strengths 
Random selection of 
participants 
Large sample size 
Limitations  
Frequency of urine 
collection may not have 
Level I, 
B 
 
68 
 
 decreases in ASI 
employment scores at 
week 26 and more 
decrease in the PSS 
total score at week 12 
and week 26. 
been sufficient to detect 
drug use 
 
Petry, 
Alessi, 
& 
Ledger
wood 
(2012) 
 
USA To assess the 
effectiveness of 
contingency 
management 
(CM) in treating 
opioid 
dependence 
 
RCT, 130 patients 
randomized to CM 
or standard care  
 
CM group remained 
longer in the study  
(9.5 ± 3.6 versus 6.7 ± 
5.0 weeks), and 
submitted a higher 
proportion of negative 
samples (57.7% ± 
40.0% versus 29.4% ± 
33.3%) than those 
assigned to standard 
care 
Strengths  
Randomization  
Limitation  
Differential rates of 
follow-up completion 
likely biased long-term 
outcome 
Provision of cash gift 
prices raises costs hence 
concerns regarding 
sustainability  
Level I, 
B 
 
Ruetsch 
et al. 
(2012) 
 
USA To assess the 
impact of 
telephonic 
patient support 
program on 
opioid dependent 
patients  
RCT, 1426 opioid 
dependent patients 
completed the 
Addiction Severity 
Index (ASI) pre and 
post-intervention 
Compared to patients 
who were non-
compliant with BUP, 
compliant patients 
reported significantly 
lower scores on all 7 of 
the ASI composite 
scores, indicating 
lower severity on 
addiction-related 
problems. 
Strength 
Huge sample size 
Generalizability  
Limitations 
Missing follow-up data 
 
 
Level I, 
B 
 
Salehi 
& 
Alizade
h 
(2018) 
 
Iran  To assess the 
effectiveness of 
CBT on relapse 
prevention in 
opioid dependent 
people  
RCT, 50 opioid 
users  
Placed into UT 
(control) or UT+ 
CBT (intervention)  
At the end of 6 
months, 84% and 48% 
of the subjects from 
the intervention and 
control groups showed 
abstinence from drug 
use, respectively. The 
findings indicated a 
significant difference 
regarding self-efficacy 
between the groups (P 
< 0.001). 
Randomization 
Limitations  
Small sample size 
92% of participants were 
males, limited diversity  
 
Level I, 
B 
 
69 
 
Weiss 
& Rao 
(2017) 
 
USA To determine the 
impact of adding 
opioid drug 
counseling to 
buprenorphine-
naloxone plus 
medical 
management on 
opioid use 
outcomes 
Two-phase RCT, 
653 participants age 
>18.  
Composite 
International 
Diagnostic 
Interview to assess 
substance misuse  
Vast majority of 
prescription opioid 
users failed to achieve 
success after tapering 
off bup-nx, whereas 
about half of the 
patients achieved 
successful outcomes 
while maintained on 
bup-nx. 
Strength 
Long follow-up period, 
42 months 
National, multi-site study 
sample  
Limitation 
Trial failed to 
demonstrate any benefits 
of adding counseling to 
UT 
Level I, 
B 
 
Zhang 
et al ( 
2017) 
 
China  To investigation 
effects of 
psychoeducation 
on treatment 
compliance, 
methadone dose, 
and heroin use 
among MMT 
clients  
Quasi experimental, 
492 MMT clients 
who tested positive 
for urine morphine 
 
During the 
intervention, urine 
morphine positive 
rates reduced to 27 % 
from 49.3 % 
previously; p < 0.001 
 
Huge sample size 
Limitation  
No comparison group 
Spurious intervention 
effect 
 
Level 
II, B 
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